Monoclonal Anti-RSV(B)-Pre-F0 specific Antibody, Human IgG1 (8E3) (MALS verified),Acro Biosystems,RSV-MY2246
Monoclonal Anti-RSV(B)-Pre-F0 specific Antibody, Human IgG1 (8E3) is a chimeric monoclonal antibody recombinantly expressed from HEK293, which combines the variable region of a mouse monoclonal antibody with Human constant domain.
Host
Mouse
Application
ELISA
Conjugate
Unconjugated
Platform ID
BAB467374846
Acro Biosystems
Contact
Tel: +1 800-810-0816
Fax:
Email:
Product Specifications
Specifications
NameMonoclonal Anti-RSV(B)-Pre-F0 specific Antibody, Human IgG1 (8E3) (MALS verified)
Cat. No.RSV-MY2246
HostMouse
IsotypeHuman IgG1 | Human Kappa
ConjugationUnconjugated
ApplicationELISA
Working Dilutions0.06-250 ng/mL
Clone Number8000
ImmunogenRecombinant HRSV (B) Pre-fusion glycoprotein F0 is expressed from human 293 cells
Purity95% as determined by SDS-PAGE.
90% as determined by SEC-MALS.
FormulationLyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
ReconstitutionPlease refer to the Certificate of Analysis (CoA) for specific instructions.
For best performance, we strongly recommend following the reconstitution protocol provided in the CoA.
StorageHuman respiratory syncytial virus (HRSV) is the most common etiological agent of acute lower respiratory tract disease in infants and can cause repeated infections throughout life. The RSV fusion glycoprotein (RSV F) is the principal target of RSV neutralizing antibodies in human sera. The RSV F is a type I viral fusion protein synthesized as inactive, single-chain polypeptides that assemble into trimers. RSV F fuses the viral and host cell membranes by irreversible protein refolding from the labile prefusion conformation to the stable post-fusion conformation.
Category Paths
- Products>Primary Antibodies>Monoclonal Antibodies
Request a product
Please provide the required information below so that we can quickly source your products.